5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

ATB Capital Markets analyst Martin Toner has to maintained his “Outperform” rating and $210.00 price target on KXS.

Spectral is a clinical-stage medical device company focused on developing therapies for critical care, particularly septic ...

Ballard Power’s disappointing Q1 2025 results prompted Roth Capital Partners analyst Craig Irwin to reaffirm his $1.25 price ...

In his May 6 corporate update, Goff said Propel’s revenue, EPS growth and ROE stand out among its fintech peers.